lupkynis 7,9 mg weichkapsel
otsuka pharmaceutical (switzerland) gmbh - voclosporinum - weichkapsel - voclosporinum 7.9 mg, ethanolum 21.57 mg, tocofersolanum, polysorbatum 40, triglycerida media, kapselhülle: gelatina, sorbitolum 28.675 mg, glycerolum, aqua purificata q.s., e 172 (flavum), e 172 (rubrum), e 171, pro capsula. - lupusnephritis der klassen iii, iv oder v bei erwachsenen - synthetika
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunsuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
sempera kapseln
janssen-cilag gmbh (8009839) - itraconazol - hartkapsel - itraconazol (23401) 100 milligramm
sempera liquid 10 mg/ml
janssen-cilag gmbh (8009839) - itraconazol - lösung zum einnehmen - itraconazol (23401) 10 milligramm
sporanox 100 mg kapseln
janssen-cilag pharma gmbh - itraconazol - itraconazol
sporanox derm 100 mg kapseln
janssen-cilag pharma gmbh - itraconazol - itraconazol
sporanox 10 mg/ml lösung zum einnehmen
janssen-cilag pharma gmbh - itraconazol - itraconazol
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
itraconazol axapharm kapseln
axapharm ag - itraconazolum - kapseln - kapsel: itraconazolum 100 mg, saccharomonospora, sphaerae 195 mg, hypromellosum, sorbitani stearas, silica colloidalis hydrica, kapselhülle: gelatine, e-171, e 172 (rubrum), pro kapsel. - antimykotikum - synthetika
sporanox kapseln
janssen-cilag ag - itraconazolum - kapseln - itraconazolum 100 mg, hypromellosum, macrogolum 20'000, sacchari sphaerae ut saccharum 175.68 mg et maydis amylum, kapselhülle: gelatina, e 127, e 132, e 171 pro capsula. - antimykotikum - synthetika